Mebendazole elicits potent antimyeloma activity by inhibiting the USP5/c-Maf axis.
Chen XH, Xu YJ, Wang XG, Lin P, Cao BY, Zeng YY, Wang Q, Zhang ZB, Mao XL, Zhang T.
Chen XH, et al. Among authors: zhang zb, zhang t.
Acta Pharmacol Sin. 2019 Dec;40(12):1568-1577. doi: 10.1038/s41401-019-0249-1. Epub 2019 Jun 13.
Acta Pharmacol Sin. 2019.
PMID: 31197245
Free PMC article.